All‐cause mortality · cirrhotic participants with large ascites treated by paracentesis
It is very uncertain whether plasma expanders changes all‐cause mortality compared with no plasma expanders (very low certainty).
1 finding from 1 review
Serious adverse events · cirrhotic participants with large ascites treated by paracentesis
1 finding from 1 review
Health‐related quality of life · cirrhotic participants with large ascites treated by paracentesis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Refractory ascites · cirrhotic participants with large ascites treated by paracentesis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Other liver‐related complications · cirrhotic participants with large ascites treated by paracentesis
It is very uncertain whether plasma expanders changes other liver‐related complications compared with no plasma expanders (very low certainty).
1 finding from 1 review
Non‐serious adverse events · cirrhotic participants with large ascites treated by paracentesis
It is very uncertain whether plasma expanders changes non‐serious adverse events compared with no plasma expanders (very low certainty).
1 finding from 1 review
Refractory ascites · cirrhotic participants with large ascites treated by paracentesis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Incidence of renal impairment · cirrhotic participants with large ascites treated by paracentesis
It is very uncertain whether other plasma expanders changes renal impairment compared with albumin (very low certainty).
1 finding from 1 review
Other liver‐related complications · cirrhotic participants with large ascites treated by paracentesis
It is very uncertain whether other plasma expanders changes other liver‐related complications compared with albumin (very low certainty).
1 finding from 1 review
Non‐serious adverse events · cirrhotic participants with large ascites treated by paracentesis
It is very uncertain whether other plasma expanders changes non‐serious adverse events compared with albumin (very low certainty).
1 finding from 1 review
All‐cause mortality · cirrhotic participants with large ascites treated by paracentesis
It is very uncertain whether other plasma expanders changes all‐cause mortality compared with albumin (very low certainty).
1 finding from 1 review
Serious adverse events · cirrhotic participants with large ascites treated by paracentesis
It is very uncertain whether other plasma expanders changes serious adverse events compared with albumin (very low certainty).
1 finding from 1 review
Health‐related quality of life · cirrhotic participants with large ascites treated by paracentesis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found